Quantcast

Industry news that matters to you.  Learn more

MolecularHealth Collaborates with SAP to Offer Innovative Employer Oncology Program

MolecularHealth recently announced the official launch of MolecularHealth™ COPE (Corporate Oncology Program for Employers), powered by its cancer treatment decision support offering, TreatmentMAP™. COPE enables self-funded employers to offer access to TreatmentMAP to their employees via a pre-packaged offering, which includes materials for employees, as well as working closely with patients’ physicians through the process of testing, analyzing and receiving results. SAP is working with MolecularHealth to become one of the first organizations to provide its employees with access to COPE and plans to offer it in the third quarter of 2014.

MolecularHealth Collaborates with SAP to Offer Innovative Employer Oncology Program

MolecularHealth recently announced the official launch of MolecularHealth™ COPE (Corporate Oncology Program for Employers), powered by its cancer treatment decision support offering, TreatmentMAP™. COPE enables self-funded employers to offer access to TreatmentMAP to their employees via a pre-packaged offering, which includes materials for employees, as well as working closely with patients’ physicians through the process of testing, analyzing and receiving results. SAP is working with MolecularHealth to become one of the first organizations to provide its employees with access to COPE and plans to offer it in the third quarter of 2014.

Truven Health Analytics Links Clinical Data with Claims to Enhance Oncology Outcomes Research

Truven Health Analytics recently announced it has successfully linked electronic medical records (EMR) and administrative claims data with significant volume to power oncology-focused outcomes research studies. This de-identified data set, the newest addition to the MarketScan® research databases, provides a unique ability for researchers to better understand total healthcare costs, co-morbidities, adverse events, and outcomes for cancer patients by treatment phase, biomarker status, and tumor stage.

MedPage Today and CollabRx Introduce CancerRx, A New Decision Support Mobile Application for Oncology

MedPage Today, a property of Everyday Health, Inc. (NYSE: EVDY), and CollabRx, Inc. (NASDAQ: CLRX) recently announced the introduction of a new physician resource, CancerRx,™ an IOS application designed to help oncologists and pathologists navigate the complex landscape of oncology therapeutic options.

Strand Genomics Inc. Announces Major Initiative With HCG To Provide Personalized Genomics Services For Oncology

Strand Genomics Inc. (Strand), a global leader in clinical genomics, recently announced a major initiative with Health Care Global Enterprises, Ltd (HCG) to provide personalized genomics services for oncology. Strand’s clinical genomics solutions for oncology offered by the Strand-Triesta Center for Cancer Genomics (Strand-Triesta) include both cancer risk assessment from saliva DNA as well as molecular diagnosis, treatment options and clinical trials recommendations based on tumor DNA. Representatives from Strand and HCG recently discussed their model for providing genomic services to healthcare providers globally at the 2014 American Society for Clinical Oncology Annual Meeting (ASCO) in Chicago.